- Mar 28, 2022
- 1 min read
Following nine clinical studies that were performed on more than 500 people in 2021, Ingredia wanted to address a core objective for all its customers: consumer satisfaction. To do so, the company:
Recruited 300 persons worldwide, in three distinct regions – the US, France and China
Applied a strict methodology with validated questionnaires and partnered with BioMerieux, utilising the company’s expertise in the area
Asked 300 participants to try Lactium at 300mg/day, reporting on either their stress indication or sleep disturbance indication.
The results are now in and Ingredia is proud to announce an overall 78% satisfaction, quite evenly split – 78% in the stress indication and 77% in the sleep disturbance indication.
Join us during Vitafoods Europe on 10-12 May, booth G100.
To find out more about Lactium, contact us: lactium.com/contact
